WALDENCAST PLC


Associated tags: Milk Makeup, DNA, Milk, Webcast, WALD, Beauty, Zein E. Obagi, Hyperpigmentation, Selfridges, Cryptocurrency, Sephora, Cosmetics, Acne, Greg Camp, Research

Locations: WHITE PLAINS, NY, US

Waldencast Regains Compliance with Nasdaq Filing Requirements

Retrieved on: 
Monday, March 25, 2024

WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq’s filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company’s financial results for the interim period ended June 30, 2023 with the U.S. Securities and Exchange Commission.

Key Points: 
  • WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq’s filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company’s financial results for the interim period ended June 30, 2023 with the U.S. Securities and Exchange Commission.
  • In line with the applicable Nasdaq Listing Rules in such circumstances, the notice also indicated that Nasdaq had imposed a “Mandatory Panel Monitor” as that term is defined in Nasdaq Listing Rule 5815(d)(4)(B), for a period of one year from the date of the compliance determination (March 21, 2024), pursuant to which in the event the Company fails to timely satisfy the Periodic Filing Rule during the one-year monitor period, the Company will not have the opportunity to provide a compliance plan for the Nasdaq Listing Qualifications Staff’s review; rather, Nasdaq would instead issue a delist determination pursuant to which the Company could request a hearing and stay of the delist determination pending another hearing before the Panel.
  • Waldencast is proud to have accomplished this significant milestone and looks forward to providing further updates on its fiscal year 2023 performance in connection with the publication of its 2023 20-F.

Waldencast Reports First Half 2023 Results

Retrieved on: 
Thursday, March 21, 2024

WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it furnished its results for the interim period ended June 30, 2023 (“H1 2023 Interim Financials”) on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/.

Key Points: 

Waldencast plc Announces Binding Letter of Intent to Acquire 60% of its Southeast Asia Distributor

Retrieved on: 
Monday, March 13, 2023

NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced today that it signed a binding letter of intent to acquire a 60% controlling interest in a newly formed entity to be comprised of the business of its Southeast Asia (SEA) distributor. The letter of intent is binding upon the SEA distributor, but Waldencast’s obligations are subject to the satisfaction of certain conditions. Assuming the satisfactory completion of its due diligence and negotiation of definitive agreements, Waldencast expects to close the transaction in the coming weeks.

Key Points: 
  • The letter of intent is binding upon the SEA distributor, but Waldencast’s obligations are subject to the satisfaction of certain conditions.
  • Assuming the satisfactory completion of its due diligence and negotiation of definitive agreements, Waldencast expects to close the transaction in the coming weeks.
  • The skincare market in Southeast Asia is approximately $11 billion1 and growing rapidly.
  • Waldencast does not undertake any obligation to provide any updates with respect to any transaction, except as required under applicable law.

Waldencast plc to Report Fourth Quarter 2022 Financial Results on March 15th

Retrieved on: 
Wednesday, March 8, 2023

NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its fourth quarter 2022 earnings results on Wednesday, March 15, 2023 at 8:30am ET.

Key Points: 
  • NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its fourth quarter 2022 earnings results on Wednesday, March 15, 2023 at 8:30am ET.
  • The fourth quarter 2022 earnings press release will be issued prior to the start of the call.
  • Investors and analysts interested in participating in the conference call are invited to dial (833) 630-1956 or (412) 317-1837 for a toll-free number.
  • A replay of the webcast will remain available on the website for 90 days.

Waldencast plc to Report Third Quarter 2022 Financial Results on November 10th

Retrieved on: 
Monday, November 7, 2022

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (Waldencast), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its third quarter 2022 earnings results on Thursday, November 10, 2022 at 8:30am ET.

Key Points: 
  • NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (Waldencast), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its third quarter 2022 earnings results on Thursday, November 10, 2022 at 8:30am ET.
  • The third quarter 2022 earnings press release will be issued prior to the start of the call.
  • Investors and analysts interested in participating in the conference call are invited to dial (646) 307-1963 or (800) 715-9871 for a toll-free number (conference ID: 6198725).
  • The first step in realizing its vision was the business combination with Obagi Skincare and Milk Makeup.

Waldencast Reports Second Quarter and First Half 2022 Results

Retrieved on: 
Thursday, August 11, 2022

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced results for the second quarter and first half of 2022.

Key Points: 
  • The Company reaffirms its previously issued outlook for Fiscal 2022 provided on November 15, 2021.
  • Waldencast plc will host a conference call to discuss second quarter and first half fiscal 2022 results today, August 11, 2022, at 8:00am ET.
  • Waldencast believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to its financial condition and results of operations.
  • For the samereasons, Waldencast is unable to address the probable significance of the unavailableinformation, which could be material to future results.

Waldencast plc to Report Second Quarter and First Half 2022 Financial Results on August 11th

Retrieved on: 
Monday, August 8, 2022

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (Waldencast), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its second quarter and first half 2022 earnings results on Thursday, August 11, 2022 at 8:00am ET.

Key Points: 
  • NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (Waldencast), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its second quarter and first half 2022 earnings results on Thursday, August 11, 2022 at 8:00am ET.
  • The second quarter and first half 2022 earnings press release will be issued prior to the start of the call.
  • The conference call will be webcast live and can be accessed at https://ir.waldencast.com/ .
  • The first step in realizing its vision was the business combination with Obagi Skincare and Milk Makeup.